Pablo Rojo Conejo

12PUBLICATIONS
45CO-AUTHORS
Disease surveillanceMajor global burdens of diseaseAdolescent healthGene and molecular therapyNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 03, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|Apr 12, 2026
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Feb 24, 2026
SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Carlos Grasa, Nicolas Salvadori, Alessandra Nardone

|Jun 06, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Nomonde Bengu, Gabriela Cromhout, Emily Adland

|Nov 19, 2021
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1.

Annalisa Dalzini, Giovanni Ballin, Sara Dominguez-Rodriguez

|Nov 09, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

Emmanuel B Walter, Kawsar R Talaat, Charu Sabharwal

Pageof 2

Frequent Collaborators

5 joint publications

Paolo Palma

2 joint publications

Nicholas Herbert

2 joint publications

Maria C Puertas

2 joint publications

Christina Ochsenbauer